Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yasutaka YAMAMOTO
Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects.
Internal Medicine
Internal Medicine
Medicine
Related publications
Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients
Gout and Nucleic Acid Metabolism
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Hypertension
Internal Medicine
Clinical Usefulness of Losartan, an Angiotensin II Receptor Antagonist With a Uricosuric Effect, and the Influence of Aspirin on the Effect in Hypertensive Patients With Hyperuricemia
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Plasma Uric Acid and Plasma Albumin in Healthy Subjects.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist on Cardiac Autonomic Functions of Rats During Acute and Chronic Inhibition of Nitric Oxide Synthesis
Physiological Research
Medicine
Physiology
The Losartan Renal Protection Study--Rationale, Study Design and Baseline Characteristics of RENAAL (Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan).
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
The Effect of Angiotensin II Receptor Blockers on Hyperuricemia
Therapeutic Advances in Chronic Disease
Medicine
Antagonist Effect of a Receptor-Mimicking Peptide Encoded by Human Angiotensin II Complementary RNA
Hypertension
Internal Medicine
Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure
Case Reports in Pediatrics
